Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 77 points (-0.5%) at 16,791 as of Thursday, June 26, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,231 issues advancing vs. 1,744 declining with 167 unchanged. The Health Care sector currently sits down 0.4% versus the S&P 500, which is down 0.4%. On the negative front, top decliners within the sector include Intercept Pharmaceuticals ( ICPT), down 4.6%, Community Health Systems ( CYH), down 3.8%, Universal Health Services ( UHS), down 3.7%, HCA Holdings ( HCA), down 2.3% and Grifols ( GRFS), down 1.6%. TheStreet would like to highlight 3 stocks pushing the sector lower today: 3. Endo International ( ENDP) is one of the companies pushing the Health Care sector lower today. As of noon trading, Endo International is down $1.27 (-1.8%) to $70.35 on light volume. Thus far, 534,685 shares of Endo International exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $70.17-$72.10 after having opened the day at $71.51 as compared to the previous trading day's close of $71.62. Endo International plc, a specialty healthcare company, develops, manufactures, markets, and distributes branded pharmaceutical and generic products, and medical devices worldwide. Endo International has a market cap of $10.7 billion and is part of the drugs industry. Shares are up 6.2% year-to-date as of the close of trading on Wednesday. Currently there are 8 analysts that rate Endo International a buy, 1 analyst rates it a sell, and 6 rate it a hold. TheStreet Ratings rates Endo International as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, expanding profit margins and notable return on equity. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, weak operating cash flow and generally higher debt management risk. Get the full Endo International Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.